“Management will update stockholders on the Comp

“Management will update stockholders on the Company's recent COVID-19 related filings for Conditional EUA with the FDA in U.S., Interim Order in Canada, and accelerated rolling review in U.K., as well as potential similar filings in Brazil and the Philippines. Management will also provide updates on its active trials in COVID-19, NASH and Cancer, along with expected timelines for BLA submissions for HIV in U.S., Canada and U.K.”


[[Recent COVID-19 related filings for conditional EUA with the rolling review in U.k. ]]


It appears to me they filed already. The title isn’t the same because it’s referring to ALL filings not just the first few.

I don’t see how this can be interpreted any other way.

Active trial(s).... I thought we only had one active trial, so did CD16 already start or maybe they are referring to the trial sites.

Federal Whistleblower
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)

Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech

https://img1.wsimg.com/blobby/go/05a949a0-169...5_FULL.pdf